Low dose effects of chemicals as assessed by the flow cytometric in vivo micronucleus assay

Using flow cytometric automation of the mouse in vivo, micronucleus assay increases the sensitivity of the test. This is achieved through a very large increase in the number of cells scored, by a factor of 100×, which in turn greatly reduces the sampling error. With this method, dose–response relationships of in vivo micronucleus induction for four model agents mitomycin C (MMC), diepoxybutane (DEB), cyclophosphamide (CPA), and colchicine (COL) were studied at low dose levels. For the three clastogens MMC, DEB and CPA, linear dose–response relationships were found over the dose ranges studied, even in the very low dose region (defined as the dose region where the frequency of micronucleated erythrocytes is less than twice the baseline frequency). This is consistent with the view that no threshold should exist for genotoxic agents which target DNA. For COL a dose range was found, in which the frequency of micronucleated erythrocytes did not increase with dose, possibly indicating an in vivo threshold. The flow cytometric in vivo micronucleus assay represents one possibility for in vivo low dose–response studies.     

A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT‐116 colon cancer cells

Colchicine is a tubulin‐binding natural product isolated from Colchicum autumnale. Here we report the in vitro anticancer activity of C‐ring modified semi‐synthetic derivative of colchicine; N‐[(7S)‐1,2,3‐trimethoxy‐9‐oxo‐10‐(4‐phenyl‐piperidin‐1‐yl)‐5,6,7,9 tetrahydrobenzo[a]heptalen‐7‐yl]acetamide ( 4h ) on colon cancer HCT‐116 cell line. The compound 4h was screened for anti‐proliferative activity against different human cancer cell lines and was found to exhibit higher cytotoxicity against colon cancer cell lines HCT‐116 and Colo‐205 with IC₅₀ of 1 and 0.8 μM respectively. Cytotoxicity of the compound to the normal fR2 breast epithelial cells and normal HEK293 human embryonic kidney cells was evaluated in concentration and time‐dependent manner to estimate its selectivity for cancer cells which showed much better selectivity than that of colchicine. Compound 4h induced cell death in HCT‐116 cells by activating apoptosis and autophagy pathways. Autophagy inhibitor 3‐MA blocked the production of LC3‐II and reduced the cytotoxicity in response to 4h , but did not affect apoptosis, suggesting thereby that these two were independent events. Reactive oxygen species scavenger ascorbic acid pretreatment not only decreased the reactive oxygen species level but also reversed 4h induced cytotoxicity. Treatment with compound 4h depolymerized microtubules and the majority of cells arrested at the G2/M transition. Together, these data suggest that 4h has better selectivity and is a microtubule depolymerizer, which activates dual cell‐death machineries, and thus, it could be a potential novel therapeutic agent in cancer therapy. Copyright © 2016 John Wiley & Sons, Ltd.     

Binding of colchicine and lumicolchicine to components in plant extracts

Irradiation of dilute, aqueous solutions of colchicine and of colcemid by long wavelength UV resulted, in each case, in a mixture of three major lumi-products whose relative concentrations depended upon the degree of UV exposure. Components in plant extracts, after concentration by ammonium sulphate precipitation, bound the drugs and their lumi-derivatives. Consideration of the different ratios of colchicine- to lumicolchicine-binding activity in different fractions of a plant extract, and after various enzymatic and temperature treatments of the plant preparations, suggest the involvement of different binding sites for the various forms of the alkaloid.     

离子注入后诱导水稻多倍化的效果

利用3份二倍体水稻为材料,以氮离子束为诱变源,研究了离子注入后所引起的生物学效应和离子注入对水稻多倍化的效果。研究结果表明,氮离子束对3份二倍体水稻材料的效应因材料种类和离子注入剂量不同而异。N 注入处理后对利用秋水仙素诱导水稻多倍化的效果比较明显,但效果的明显程度则因离子注入剂量不同或秋水仙素诱导时间不同或试验材料的遗传背景不同而表现出一定的差异。在秋水仙素对试验材料的诱导时间为24 h的各个处理中,N 离子注入剂量为6.76×1016N /cm2的处理似乎更好,而在秋水仙素对试验材料的诱导时间为48 h的各个处理中,N 离子注入剂量为0.52×1016N /cm2的处理则更有利于获得同源四倍体材料。经过2个~3个世代的筛选之后并通过染色体核型分析,在试验材料的后代中已经获得了一些同源四倍体水稻材料。     

Synthesis,biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents

Colchicine is the major alkaloid isolated from the plant Colchicum autumnale, which shows strong therapeutic effects towards different types of cancer. However, due to the toxicity of colchicine towards normal cells its application is limited. To address this issue we synthesized a series of seven triple-modified 4-bromothiocolchicine analogues with amide moieties. These novel derivatives were active in the nanomolar range against several different cancer cell lines and primary acute lymphoblastic leukemia cells, specifically compounds: 5–9 against primary ALL-5 (IC₅₀ = 5.3–14 nM), 5, 7–9 against A549 (IC₅₀ = 10 nM), 5, 7–9 against MCF-7 (IC₅₀ = 11 nM), 5–9 against LoVo (IC₅₀ = 7–12 nM), and 5, 7–9 against LoVo/DX (IC₅₀ = 48–87 nM). These IC₅₀ values were lower than those obtained for unmodified colchicine and common anticancer drugs such as doxorubicin and cisplatin. Further studies revealed that colchicine and selected analogues induced characteristics of apoptotic cell death but manifested their effects in different phases of the cell cycle in MCF-7 versus ALL-5 cells. Specifically, while colchicine and the studied derivatives arrested MCF-7 cells in mitosis, very little mitotically arrested ALL-5 cells were observed, suggesting effects were manifest instead in interphase. We also developed an in silico model of the mode of binding of these compounds to their primary target, β-tubulin. We conducted a correlation analysis (linear regression) between the calculated binding energies of colchicine derivatives and their anti-proliferative activity, and determined that the obtained correlation coefficients strongly depend on the type of cells used.     

秋水仙素诱导七里香多倍体

以不同浓度（0．02％、0．04％、0．08％、0．16％）秋水仙素溶液与二甲基亚砜和丙草胺的体积混合比为2000：10：1的溶液诱导七里香种子萌发苗1-3d的结果表明,所有处理均得到七里香多倍体,其中以秋水仙素浓度为0．08％的混合液处理3d的诱导效果最好,多倍体诱导率迭36．7％。     

Increased autophagy accelerates colchicine-induced muscle toxicity

Colchicine treatment is associated with an autophagic vacuolar myopathy in human patients. The presumed mechanism of colchicine-induced myotoxicity is the destabilization of the microtubule system that leads to impaired autophagosome-lysosome fusion and the accumulation of autophagic vacuoles. Using the MTOR inhibitor rapamycin we augmented colchicine’s myotoxic effect by increasing the autophagic flux; this resulted in an acute myopathy with muscle necrosis. In contrast to myonecrosis induced by cardiotoxin, myonecrosis induced by a combination of rapamycin and colchicine was associated with accumulation of autophagic substrates such as LC3-II and SQSTM1; as a result, autophagic vacuoles accumulated in the center of myofibers, where LC3-positive autophagosomes failed to colocalize with the lysosomal protein marker LAMP2. A similar pattern of central LC3 accumulation and myonecrosis is seen in human patients with colchicine myopathy, many of whom have been treated with statins (HMGCR/HMG-CoA reductase inhibitors) in addition to colchicine. In mice, cotreatment with colchicine and simvastatin also led to muscle necrosis and LC3 accumulation, suggesting that, like rapamycin, simvastatin activates autophagy. Consistent with this, treatment of mice with four different statin medications enhanced autophagic flux in skeletal muscle in vivo. Polypharmacy is a known risk factor for toxic myopathies; our data suggest that some medication combinations may simultaneously activate upstream autophagy signaling pathways while inhibiting the degradation of these newly synthesized autophagosomes, resulting in myotoxicity.     

LOCALIZATION OF CA2+-STIMULATED ATPASE IN THE COCCOLITH-PRODUCING COMPARTMENT OF CELLS OF PLEUROCHRYSIS SP. (PRYMNESIOPHYCEAE)1

Cell homogenates of Pleurochrysis sp. (CCMP299) were fractionated by means of sucrose gradients. Ca²⁺-stimulated ATPase (EC 3.6.1.3., ATP phosphohydrolase) was associated primarily with the plasma membrane, Golgi, and high density (1.21 g·cm^?3) membranous structures. Ca²⁺-stimulated ATPase was highly enriched in the latter. Based on treatments with Triton X-100 and NBD ceramide, we conclude that the high-density structures were membrane-delimited organelles. These vesicle-like organelles contained complex polysaccharides, a high concentration of calcium, and, upon microscopic examination, structures resembling coccoliths. These findings are consistent with observations on the known composition of coccoliths and the presumed mineralizing function of the sub-cellular coccolith-producing compartment. The high-density vesicles were linked to the Golgi by means of colchicine-sensitive materials, presumably microtubules. These data and prior ultrastructural observations by other investigators indicating vectorial assembly and secretion suggest that the subcellular movement of the newly formed coccoliths may be directed and/or powered by colchicine-sensitive cytoskeletal elements. We interpret the data to mean that the high-density vesicles represent the coccolith-producing compartment previously observed by others in electron micrographs.     

铁皮石斛2n花粉诱导及其形成的细胞机制研究

以铁皮石斛花蕾为材料,研究不同秋水仙素处理对2n花粉诱导的影响,并探讨2n花粉形成的细胞机制。结果表明:用0.1%秋水仙素微量注射长5.53mm、宽2.3mm左右的花蕾,每天注射1次,共注射3次,诱导2n花粉效果最好,2n花粉诱导率达6.22%,2n花粉粒直径比n花粉粒直径增大49%。减数分裂中期Ⅱ发现纺锤体定位异常,表现为平行纺锤体、三级纺锤体,四分体时期观察到三分体和二分体,故纺锤体定位异常可能是铁皮石斛2n配子形成的细胞学机制之一,其2n花粉在遗传上等同于FDR型。